chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Severe chills/ aches/sweating/headache for 3 days after 2nd injection.  This came on on the 4th or 5th day after injection and was so severe, I called a physician to determine if I needed more medical assistance.  Two weeks after injection, still having health issues.  The lab work showed these issues:  low hemoglobin,  low red cell count, low hematocrit, high glucose, high bilirubin, high BUN.  Some issues starting to resolve after 4 weeks but still fatigued with exertion.
Patient received her FLUZONE HIGH DOSE vaccine at 4:30 pm on Monday (01/13). Later in the pm she stated she experienced swelling an redness on her (L) arm. She did not seek med. attention and stated it was better the next day. Notified pharmacy on Friday (1/17). She reported feeling weakness at 6:30 pm, but did not notice redness until the next morning (8 am).
EYE SENSITIVITY; FEVER; INJECTION SITE SORENESS; HEADACHE; TIREDNESS; This spontaneous report received from a patient concerned a 23 year old female. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 042A21A, expiry: UNKNOWN) dose was not reported, administered on 15-JUN-2021 for prophylactic vaccination. No concomitant medications were reported. On 15-JUN-2021, the subject experienced eye sensitivity. On 15-JUN-2021, the subject experienced fever. On 15-JUN-2021, the subject experienced injection site soreness. On 15-JUN-2021, the subject experienced headache. On 15-JUN-2021, the subject experienced tiredness. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from fever on 16-JUN-2021, and had not recovered from injection site soreness, headache, eye sensitivity, and tiredness. This report was non-serious.
36 Hours later I noticed that I was scratching my  knuckles.. Very red and inflamed  and tiny bumps .. One knuckles on left hand and two knuckles on my right hand
pain in lt leg; refused to put weight on leg; leg was swollen in thigh & ankle; pain became apparent @ about 9AM & was gone by 5PM; pt was given Advil (one dose the 1st day) & one dose the second day;
REDNESS, SWELLING, BURNING, WARM TO TOUCH ON RIGHT ARM BEGAN 9/15/21.  WENT TO URGENT CARE, DX WITH SKIN INFECTION, PLACED ON BENADRYL AND PRESCRIBED ANTIBIOTIC.
Pt woke up on 1/27 at approximately 0300 , stood up and fainted.  Husband states she was unresponsive for about 5 minutes.  EMS was called, arrived & evaluated the patient.  Patient did not go to the hospital.  Patient's also noticed shaking & chills for about 1 hour after the incident.  She state she slept for a couple hours and the next day she didn't have any energy.  Pt reports that on 1/28 she felt better with a minor headache and neck pain.  Pt did not seek out her PCP after the incident.
vaccine that had went into 2-8 C thaw state on or about 24-Dec-2021 and administered on 28-Jan-2022; patient received vaccine past its 30 days expiry date; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (patient received vaccine past its 30 days expiry date) and PRODUCT STORAGE ERROR (vaccine that had went into 2-8 C thaw state on or about 24-Dec-2021 and administered on 28-Jan-2022) in a 44-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 066H21A) for COVID-19 vaccination.     No Medical History information was reported.    On 28-Jan-2022 at 5:01 PM, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 28-Jan-2022 at 5:01 PM, the patient experienced EXPIRED PRODUCT ADMINISTERED (patient received vaccine past its 30 days expiry date). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (vaccine that had went into 2-8 C thaw state on or about 24-Dec-2021 and administered on 28-Jan-2022). At the time of the report, EXPIRED PRODUCT ADMINISTERED (patient received vaccine past its 30 days expiry date) and PRODUCT STORAGE ERROR (vaccine that had went into 2-8 C thaw state on or about 24-Dec-2021 and administered on 28-Jan-2022) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Patient received Booster dose.   No concomitant medications were reported. No treatment details were reported.
SUBCUTANEOUS NEEDLE WAS USED TO ADMINISTER INTRAMUSCULAR VACCINE; OFF LABEL USE; This spontaneous report received from a pharmacist concerned a patient of unspecified age and sex. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1855194, and expiry: UNKNOWN) dose was not reported, administered on 12-DEC-2021 for prophylactic vaccination. No concomitant medications were reported.  On 12-DEC-2021, the patient experienced subcutaneous needle was used to administer intramuscular vaccine. On 12-DEC-2021, the patient experienced off label use. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the subcutaneous needle was used to administer intramuscular vaccine and off label use was not reported. This report was non-serious.
Mother called at 10:00am shortly after Hep B #3 given.  Reports child has quarter size red/swollen area with numbness in arem (lt).  Advised to apply cold compress and call PMD for evaluation.  Denies other symptom.  Advised to call HD to report further tx/problems.
This spontaneous report was received from a registered nurse refers to a patient of unknown age. On an unspecified date the patient might have been vaccinated with a dose of PNEUMOVAX23 (dose, route, lot# unknown) that was exposed to an unsupported temperature excursion (9C for 108 hours total over three separate excursions on unspecified dates). No adverse effect reported. Additional information has been requested.
This spontaneous report as received from a physician via company representative refers to a patient of unknown age and unspecified gender. On 06-FEB-2014 the patient was vaccinated with the dose of M-M-R II (lot # J006954, expiration date: 07-JUN-2015; route and anatomical location of administration not reported), 1 vial. According to reporting physician on 18-FEB-2014, the patient developed "measles like rash" after receiving M-M-R II. There was no treatment given for the event. The outcome of measles like rash was reported as recovered/resolved on an unknown date in 2014. The patient sought medical attention by consulting the physician. The relatedness between reported event and M-M-R II administration was not reported. This case is linked to MARRS# 1403USA010827 and 1403USA011146 (same reporter link). Additional information has been requested.
This case was reported by a consumer via call center representative and described the occurrence of injection site pain in a 60-year-old male patient who received SHINGRIX for prophylaxis. Concurrent medical conditions included diabetes. On an unknown date, the patient received the 1st dose of SHINGRIX. On an unknown date, less than a year after receiving SHINGRIX, the patient experienced injection site pain. On an unknown date, the outcome of the injection site pain was unknown. It was unknown if the reporter considered the injection site pain to be related to SHINGRIX. Additional details were reported as follows: The age at vaccination was not reported. Limited information was provided by the caller. The caller reported that her brother experienced side effects after taking SHINGRIX. For tolerance after 2nd dose refer case US2018208946.
This spontaneous case reported by a consumer, describes the occurrence of psoriasis (broke-out in a psoriatic skin eruption) and rash (had a rash ever since) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 vaccine) for COVID-19 immunization. Concurrent medical conditions included psoriasis. On an unknown date, patient received the first dose of mRNA-1273 (Moderna COVID-19 vaccine), unknown route; 1 dosage form. On an unknown date, patient received the second dose of mRNA-1273 (Moderna COVID-19 vaccine), unknown route; 1 dosage form. On an unknown date, patient experienced psoriasis (broke-out in a psoriatic skin eruption) and rash (had a rash ever since). At the time of the report, psoriasis (broke-out in a psoriatic skin eruption) and rash (had a rash ever since) outcome: unknown. No concomitant medication or treatment information provided. Patient had her 1st Moderna dose mid-March and her 2nd dose about a month later.
unknown if vaccine related-pt reportedly positive for covid 8/29/21 with symptoms of fatigue, myalgias, chills and cough. recovered. but 11/9 became feverish, cough, h/a and vomited.  11/13/2021 admitted and dx with mild  MIS-C.  Elevated tropinin, cough, sob, elevated D dimers, thrombophilia, abd pain, vomiting, head ache, myalgia, hypotension.  treated with steroids, antiplatelets, anticoagulant, and 2 dose IVIG. Positive for covid 11/13/2021 by PCR and IgG, negative IgM. --found while reporting MIS-C case. reporting in VAERS now since unsure if already reported in VAERS.  RN.
Tightness in her throat on & off since receiving the GARDASIL vaccine on 1/8/13.
Saturday woke at 2am with high pitched unusual cry was in a cold sweat, no fever, arms stiff by her side, kicking legs out, eyes open and saying "no, no, no". Lasted 20mins. During lunch on Sunday pushed plate away, body stiffened, head shook for a few seconds. Bit lip, looked pale. Recovered in 5 minutes.
nonverbal.  Fatigued after vaccine.  Never improved.  Right lower extremity swelling on 10/15.  subsequently shaky. CK 200,000 on admission 11/5.
feels tired; Wheezing; Coughing; rattling in her throat; This is a spontaneous report received from a contactable consumer or other non hcp. A 87-years-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, Batch/lot number was not reported) via an unspecified route of administration on 08Mar2021 at 11:00 (age at vaccination 87years old) as single dose for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient experienced wheezing, coughing, rattling in her throat on 09Mar2021, feels tired on an unspecified date. She originally provides her name as (patient name) and then says that is actually her sister's name that she gave because her sister got the COVID vaccine. She confirms that the number provided, and populated in formal field, is her own. She was reporting on her sister, says that her sister woke up wheezing and coughing and she is 87 years old. The caller is wanting to report this, so it is put on the list of things that have happened after the COVID vaccine. The caller does not know if it is from the COVID vaccine, but her sister has not ever wheezed before. Her sister was wheezing Tuesday morning, 09Mar2021, and then again, this morning, 11Mar2021. The caller says that she had already had both of her COVID vaccines, and she is calling for her sister. Their other sister had tried to call yesterday, but it said that there were 18 people ahead of her, so she got discouraged and hung up. The patient underwent lab tests and procedures which included weight: 220 lbs on unspecified date she thinks 220 pounds maybe, but she is unsure. The clinical outcome of the event feels tired was unknown and other events wheezing, coughing, rattling in her throat was recovered on 11Mar2021.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Patient received incorrect vaccine brand  for the second dose. 1st dose of Moderna was administered on 05/26/2021.
lump under arm pit; neck pain; severe pain at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of NECK PAIN (neck pain), NODULE (lump under arm pit) and VACCINATION SITE PAIN (severe pain at the injection site) in a 33-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 19-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-Feb-2021, the patient experienced VACCINATION SITE PAIN (severe pain at the injection site). On 22-Feb-2021, the patient experienced NECK PAIN (neck pain). On 26-Feb-2021, the patient experienced NODULE (lump under arm pit). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. On 22-Feb-2021, VACCINATION SITE PAIN (severe pain at the injection site) outcome was unknown. At the time of the report, NECK PAIN (neck pain) and NODULE (lump under arm pit) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
(R) arm of ZOSTAVAX injection swelled around area and extended approx 5 inches diameter. Site was warm and "itchy". Pt also reported a yeast infection 1 day after injection.
Waited 15 minutes, client stood up walked away fell to the dock floor and blacked out. His pupils became pin point, pale, diaphoretic, dry mouth and reported mouth taste like aluminum. Blood pressure low and difficult to be detected, kept taking BP, pulse, low reading, provided Epinephren . BP was 119/79 (5th B/P). Alert and aware of situation.
Information has been received from a registered nurse concerning a patient who was vaccinated with a dose of varicella virus vaccine live. Subsequently, the patient experienced breakthrough disease. Follow up information indicated that the registered nurse could not provide additional information at this time. Additional information is not expected.
Dizziness, "flutters" (heart palpitations), chest heaviness, short of breath.
Pt given Tdap (L) deltoid 4-10-18. Pt had pain afterward. Day later pt had swelling lymph node under (L) arm. Next day 4-12 woke up with substantial swelling. (L) supraclavicular lymph node. Tender, no fever, some fatigue. Pt has never had reaction like this in past. Assessment/Plan: Lymph node swelling likely due to robust immune response to vaccine. Will give oral Prednisone 40 mg daily x 5 days for pain, swelling. Educate use of Ibuprofen prn pain. Return precautions given.
LOWER LEG PAIN; This spontaneous report received from a consumer concerned a male of unspecified age. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 042A21A expiry: UNKNOWN) dose was not reported, administered on 10-APR-2021 for prophylactic vaccination. No concomitant medications were reported. On 16-APR-2021, the patient experienced lower leg pain. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from lower leg pain on 16-APR-2021. This report was non-serious. This case, from the same reporter is linked to 20210525539.
Patient began having intermittent twitching of eyelids and shoulders, about 6 times on 1/16. Admitted to hospital for observation.
This non-serious spontaneous case, was initially received on 23-Oct-2017 from a Pharmacist, concerns a 44-year-old adult female patient. On 23-Oct-2017, the patient was administered with FLUCELVAX QIV (dose: 0.5 ml, batch no: 195210A, expiry date: Mar-2018, route of administration: intramuscular and anatomical location: left deltoid). It was reported that vaccine was at a maximum temperature of 55F overnight and it was administered. The pharmacist stated that the refrigerator was 40.6F last night but that morning the temperature was 55F and that was a first-time excursion. It was reported that, the patient did not experience any adverse event after the administration of the vaccine. The reporter did not provide the seriousness assessment. Follow-up report received on 27-Nov-2017: Gender of the patient (female) was added. Route of administration (intramuscular), anatomical location: left deltoid was updated. Amended narrative accordingly. Significant case correction received with IRD 27-Nov-2017: The event 'no adverse event' was deleted.
My lip fillers that I received in Summer 2020 are swollen. Day after and two days after my vaccine, swelling seems to be going down after a day.
ACUTE NON ST ELEVATION MI 8/10/2021 POSTHERPETIC NEURALGIA
Fever from 6pm-12:30am the day of the shot.   Severe soreness and redness in injection site still 2 days later:
my left arm went bad-could not raise arm; my left arm went bad-could not raise arm/could not hold glass; left leg was numb, and hurting; left leg was numb, and hurting; the sciatic nerve had been inflamed irritated; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 81 year-old patient received bnt162b2 (BNT162B2), administered in arm left, administration date Apr2021 (Batch/Lot number: unknown) as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: PAIN IN EXTREMITY (non-serious) with onset 2021, outcome "unknown", described as "my left arm went bad-could not raise arm"; HYPOAESTHESIA (non-serious) with onset 2021, outcome "unknown", described as "my left arm went bad-could not raise arm/could not hold glass"; HYPOAESTHESIA (non-serious), PAIN IN EXTREMITY (non-serious) all with onset 2021, outcome "unknown" and all described as "left leg was numb, and hurting"; SCIATIC NERVE INJURY (non-serious) with onset 2021, outcome "unknown", described as "the sciatic nerve had been inflamed irritated". The events "my left arm went bad-could not raise arm", "my left arm went bad-could not raise arm/could not hold glass", "left leg was numb, and hurting", "left leg was numb, and hurting" and "the sciatic nerve had been inflamed irritated" were evaluated at the physician office visit. Therapeutic measures were taken as a result of pain in extremity, hypoaesthesia, hypoaesthesia, pain in extremity, sciatic nerve injury. Additional information: After the second shot patient's left arm went dead- could not raise arm, could not hold glass, also patient's left arm was numb, and hurting. In about 10 days with exercise patient's arm was better-the pain in leg diminished but did not disappear. The patient had consulted a chiropractor, the sciatic venue had been irritated, treatment had been some help but did not eradicate all pain.  The lot number for bnt162b2 was not provided and will be requested during follow up.
Patient phoned 3 days post vaccine. Reported, received H1N1 vaccine on 11-14-09. Woke up next am with hoarseness, wheezing, fever, and stiff neck. Has inhaler used albuterol inhaler did not seek any medical care, rested, patient started feeling better she states on 11-17-09.
Patient nearly lost consciousness about 10 minutes after receiving vaccine. His eyes rolled back and he was initially not very responsive. However, after calling his name and grabbing his arm, he came to. He was able to answer questions weakly. He reported feeling thirsty, dizzy, and cold. He was given water. He vomited. Emergency services were called. He eventually reported starting to feel better and refused to go to the hospital.
3/18/21-0750 AM received vaccine, patient then experienced extreme itching throughout body and fatigue. Patient states that she was having itching to throat and sneezing. Pt. took claritin around 10 am. Then around 1045 patient states that she started having headache and feels like she is coming down with a cold as well. Patient states that she is still itching from scalp all the way down to her knees. Pt. states that itching is tolerable. Denies hives, denies trouble breathing, denies shortness of breath.
First 24 hours, arm pain/ discomfort at injection site only At 24 hours, mild myalgias/ arthralgias and low grade fever At 30 hours, progressive worsening of myalgias/ arthralgias and fevers/ chills/ rigors; TMax 102.0 F At 36 hours, severe myalgias/ arthralgias, continued fever unresponsive to administration of antipyrectics, and onset of nausea PCP contacted, aware of reactions, recommended conservative management  At 48 hours, continuation of above symptoms, all severe and unrelieved with supportive care Day #3:  Fevers improved, myalgias/ arthralgias resolving, mild nausea and abdominal discomfort Day #4:  Low grade fevers continue, no myalgias/ arthralgias, worsening nausea, abdominal discomfort, onset of diarrhea; irritable and fatigued Day #5:  Low grade fevers continue, nausea, abdominal discomfort, diarrhea, inability to tolerate PO intake, worsening fatigue Day #6:  Fevers resolved.  Nausea, abdominal discomfort, diarrhea, inability to tolerate PO intake and fatigue persists Day #7:  Diarrhea resolved.  Nausea, abdominal discomfort improved, tolerating some PO, fatigue persists Day #8:  Worsening of nausea, abdominal discomfort with PO intake, tolerating minimal PO, fatigue persists Week 2:  Nausea improving, abdominal discomfort improving, PO intake improving, fatigue persists
swollen lymph node under my left arm pit; very sore neck and shoulders; a very sore neck and shoulders; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 42 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date May2021 (Batch/Lot number: unknown) at the age of 42 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "Known allergies: Broccoli, chocolate, plumbs, wheat,bakers yeast etc." (unspecified if ongoing). Concomitant medication(s) included: ADVIL [IBUPROFEN]; TYLENOL.  The following information was reported: LYMPHADENOPATHY (non-serious) with onset May2021, outcome "not recovered", described as "swollen lymph node under my left arm pit"; NECK PAIN (non-serious) with onset May2021, outcome "not recovered", described as "very sore neck and shoulders"; ARTHRALGIA (non-serious) with onset May2021, outcome "not recovered", described as "a very sore neck and shoulders". The events "swollen lymph node under my left arm pit", "very sore neck and shoulders" and "a very sore neck and shoulders" were evaluated at the physician office visit. The patient underwent the following laboratory tests and procedures: sars-cov-2 test: (Jun2021) negative; (Jul2021) negative; (Aug2021) negative. Therapeutic measures were taken as a result of lymphadenopathy, neck pain, arthralgia.  Additional information:  Patient reported that since vaccine, the patient was also apparently allergic to foods and environmental things that she had never been allergic to in her whole life.   This follow-up is being submitted to notify that the lot/batch number is not available despite the follow-up attempts made. Follow-up attempts completed. No further information is expected.
6 days after MMR, developed a macular rash. On exam: About 25 scattered macules over entire body.
Within a day or two my shoulder hurt considerably and continued to for the next 1 year.  Secondly - my left hand joints/knuckles have all swollen, especially my left index finger which is no longer usable due to pain.  It has affected my right hand also, but not as bad.